MannKind | MNKD - Interest Income

Stock Price
2.52
Daily Change
-0.09 -3.45%
Monthly
-54.51%
Yearly
-52.09%
Q1 Forecast
2.69

MannKind reported $2.63M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Adma Biologics USD 376K 24K Sep/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Eli Lilly USD 65M 25M Sep/2025
Insmed USD 765K 55K Sep/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.53M 114K Sep/2025
MannKind USD 2.63M 796K Sep/2025
Merck USD 96M 27M Sep/2025
Novavax USD 303K 27K Dec/2021
Novo Nordisk DKK 3.42B 2.04B Mar/2025
Pfizer USD 0.62 156M Sep/2025
Sanofi EUR 114M 38M Sep/2025
Xencor USD 6.54M 710K Sep/2025